Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Depreciation and Depletion (2016 - 2017)

Historic Depreciation and Depletion for Prestige Consumer Healthcare (PBH) over the last 7 years, with Q1 2017 value amounting to $1.7 million.

  • Prestige Consumer Healthcare's Depreciation and Depletion rose 1333.33% to $1.7 million in Q1 2017 from the same period last year, while for Mar 2017 it was $6.0 million, marking a year-over-year increase of 1538.46%. This contributed to the annual value of $9.7 million for FY2025, which is 1829.27% up from last year.
  • Prestige Consumer Healthcare's Depreciation and Depletion amounted to $1.7 million in Q1 2017, which was up 1333.33% from $1.3 million recorded in Q4 2016.
  • Prestige Consumer Healthcare's Depreciation and Depletion's 5-year high stood at $1.7 million during Q1 2017, with a 5-year trough of $500000.0 in Q3 2013.
  • For the 5-year period, Prestige Consumer Healthcare's Depreciation and Depletion averaged around $1.1 million, with its median value being $1.2 million (2015).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Depreciation and Depletion soared by 50000.0% in 2013, and later tumbled by 909.09% in 2014.
  • Prestige Consumer Healthcare's Depreciation and Depletion (Quarter) stood at $1.1 million in 2013, then decreased by 9.09% to $1.0 million in 2014, then grew by 20.0% to $1.2 million in 2015, then rose by 8.33% to $1.3 million in 2016, then soared by 30.77% to $1.7 million in 2017.
  • Its Depreciation and Depletion was $1.7 million in Q1 2017, compared to $1.3 million in Q4 2016 and $1.5 million in Q3 2016.